Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs-Reference-Cited by-同舟云学术

Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs

Published:2019-06-25 Issue:24 Volume:321 Page:2403
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Phillips Kathryn A.¹²,Trosman Julia R.¹³,Douglas Michael P.¹

Affiliation:

1. Center for Translational and Policy Research on Personalized Medicine, Department of Clinical Pharmacy, University of California, San Francisco

2. Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco

3. Center for Business Models in Healthcare, Chicago, Illinois

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jama/article-pdf/321/24/2403/17671834/jama_phillips_2019_vp_190068.pdf

Reference8 articles.

1. Direct-to-consumer genetic testing.;Gill;JAMA,2018

2. Gatekeepers or intermediaries?;McGowan;PLoS One,2014

3. Cost comparison of genetic testing strategies in women with epithelial ovarian cancer.;Foote;J Oncol Pract,2017

4. US Securities and Exchange Commission. Invitae annual report: form 10-K. http://d18rn0p25nwr6d.cloudfront.net/CIK-0001501134/303998a9-82bc-4c5c-ba26-7043c13adb0c.pdf. Accessed March 25, 2019.

5. National Institutes of Health. National Institutes of Health genetic testing registry. https://www.ncbi.nlm.nih.gov/gtr/. Accessed March 26, 2019.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public Perspectives on Direct-to-Consumer Testing Oversight;Therapeutic Innovation & Regulatory Science;2024-08-17

2. Direct-to-Consumer Genetic Testing: A Comprehensive Review;Therapeutic Innovation & Regulatory Science;2023-08-17

3. Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women;Journal of Community Genetics;2022-04-29

4. Laboratory business models and practices: implications for availability and access to germline genetic testing;Genetics in Medicine;2021-09

5. Influence of payer coverage and out‐of‐pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings;Journal of Genetic Counseling;2021-07-07